Melodi Health Closes $10.75M Series A
Melodi Health, a Minneapolis-based medical device company, has announced two major milestones: the successful closing of an oversubscribed $10.75 million Series A financing round and the launch of the “ARIA” investigational device exemption (IDE) trial. The trial aims to improve clinical outcomes for women undergoing breast reconstruction after mastectomy. The company, founded in February 2021, … Read more